-
公开(公告)号:US20040242566A1
公开(公告)日:2004-12-02
申请号:US10809638
申请日:2004-03-24
申请人: Syrrx, Inc.
发明人: Jun Feng , Stephen L. Gwaltney , Stephen W. Kaldor , Jeffrey A. Stafford , Michael B. Wallace , Zhiyuan Zhang
IPC分类号: A61K031/549 , A61K031/517 , A61K031/519
CPC分类号: C07D471/04 , C07D401/04 , C07D403/04 , C07D473/18 , C07D487/04
摘要: Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and othe S9 proteases that comprise a compound comprising the formula: 1 wherein Q is selected from the group consisting of CO, SO, SO2, or CnullNR9; and R1, R2, R3 and R4 as defined herein.
摘要翻译: 提供化合物,药物,试剂盒和方法用于DPP-IV和S9蛋白酶,其包含下式的化合物:其中Q选自CO,SO,SO 2或C = NR 9; 和如本文所定义的R 1,R 2,R 3和R 4。
-
公开(公告)号:US20040266769A1
公开(公告)日:2004-12-30
申请号:US10803344
申请日:2004-03-17
申请人: Syrrx, Inc.
发明人: Jerome C. Bressi , Jason W. Brown , Sheldon X. Cao , Anthony R. Gangloff , Andrew J. Jennings , Jeffrey A. Stafford , Phong H. Vu , Xiao-Yi Xiao
IPC分类号: A61K031/535 , A61K031/53 , A61K031/52 , A61K031/519
CPC分类号: C07D235/18 , C07D401/04 , C07D401/06 , C07D403/06 , C07D403/10
摘要: Compounds that may be used to inhibit histone deacetylase having the formula Z-Q-L-M or Z-L-M wherein M is a substituent capable of complexing with a deacetylase catalytic site and/or a metal ion; L is a substituent providing between 0-10 atoms separation between the M substituent and the remainder of the compound; and Z and Q are as defined herein.
-
公开(公告)号:US20040259870A1
公开(公告)日:2004-12-23
申请号:US10809637
申请日:2004-03-24
申请人: Syrrx, Inc.
发明人: Jun Feng , Stephen L. Gwaltney , Stephen W. Kaldor , Jeffrey A. Stafford , Michael B. Wallace , Zhiyuan Zhang
IPC分类号: A61K031/5395
CPC分类号: C07D471/04 , C07D401/04 , C07D403/04 , C07D473/18 , C07D487/04
摘要: Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 protease that comprise a compound comprising the formula: 1 wherein Q is selected from the group of CO, SO, SO2, or CnullNR9; and R1, R2, R3 and R4 are as defined herein.
摘要翻译: 提供化合物,药物,试剂盒和方法用于DPP-IV和其它S9蛋白酶,其包含下式的化合物:其中Q选自CO,SO,SO 2或C = NR 9; 并且R 1,R 2,R 3和R 4如本文所定义。
-
公开(公告)号:US20040242568A1
公开(公告)日:2004-12-02
申请号:US10809636
申请日:2004-03-24
申请人: Syrrx, Inc.
发明人: Jun Feng , Stephen L. Gwaltney , Stephen W. Kaldor , Jeffrey A. Stafford , Michael B. Wallace , Zhiyuan Zhang
IPC分类号: A61K031/549 , A61K031/513 , C07D417/02
CPC分类号: C07D471/04 , C07D401/04 , C07D403/04 , C07D473/18 , C07D487/04
摘要: Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising the formula: 1 wherein Q is selected from the group consisting of CO, SO, SO2, or CnullNR9; and R1, R2, R3 and R4 are as defined herein.
摘要翻译: 提供化合物,药物,试剂盒和方法用于DPP-IV和其它S9蛋白酶,其包含下式的化合物:其中Q选自CO,SO,SO 2或C = NR 9; 并且R 1,R 2,R 3和R 4如本文所定义。
-
公开(公告)号:US20040254226A1
公开(公告)日:2004-12-16
申请号:US10846348
申请日:2004-05-13
申请人: Syrrx, Inc.
发明人: Jun Feng , Stephen L. Gwaltney , Jeffrey A. Stafford , Michael B. Wallace , Xiao-Yi Xiao , Zhiyuan Zhang
IPC分类号: C07D213/24 , A61K031/13 , C07D207/46 , A61K031/44 , A61K031/40
CPC分类号: C07K5/06026 , C07D207/16 , C07D277/04 , C07D401/12 , C07K5/06043
摘要: Pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound with the formula: 1 where the labeled substituents are as described herein.
摘要翻译: 提供药物,试剂盒和方法用于DPP-IV和其它S9蛋白酶,其包含下式的化合物:其中标记的取代基如本文所述。
-
公开(公告)号:US20040254220A1
公开(公告)日:2004-12-16
申请号:US10803575
申请日:2004-03-17
申请人: Syrrx, Inc.
发明人: Jerome C. Bressi , Jason W. Brown , Sheldon X. Cao , Anthony R. Gangloff , Andrew J. Jennings , Jeffrey A. Stafford , Phong H. Vu , Xiao-Yi Xiao
IPC分类号: A61K031/454 , C07D43/04
CPC分类号: C07D235/18 , C07D401/04 , C07D401/06 , C07D403/06 , C07D403/10
摘要: Compounds that may be used to inhibit histone deacetylase having the formula Z-Q-L-M or Z-L-M wherein M is a substituent capable of complexing with a deacetylase catalytic site and/or a metal ion; L is a substituent providing between 0-10 atoms separation between the M substituent and the remainder of the compound; and Z and Q are as defined herein.
摘要翻译: 可用于抑制具有式Z-Q-L-M或Z-L-M的组蛋白脱乙酰酶的化合物,其中M是能够与脱乙酰酶催化位点和/或金属离子络合的取代基; L是在M取代基和化合物的其余部分之间分离0-10个原子之间的取代基; Z和Q如本文所定义。
-
-
-
-
-